Central Nervous System: Is creatine a CNS neurotransmitter?

A range of experiments suggests that creatine, a molecule known for recycling ATP in muscle and brain tissue, may also function as a neurotransmitter in the central nervous system.
  1. Bhagaban Mallik
  2. C Andrew Frank  Is a corresponding author
  1. Department of Anatomy and Cell Biology, University of Iowa, United States

Communication in the nervous system relies on neurons transmitting signals to target cells. This process is facilitated by various chemicals, including neurotransmitters, neuromodulators and neuropeptides (Langley, 1905; Benfenati and Agnati, 1991; Lovinger, 2008). Identifying a new neurotransmitter is no small feat: such a discovery requires extensive investigation and validation, and it might take decades to integrate the collective contributions of many different research groups (Hökfelt, 2010; Contestabile, 2011). Moreover, neurotransmitters that act in peripheral tissues, like muscle, are easier to identify than those that act on the central nervous system (CNS). It is likely that many CNS neurotransmitters have not yet been identified (Curtis et al., 1959; Carlsson et al., 1962; Curtis and Watkins, 1963; Björklund et al., 1968; Andersson, 2000).

To be classified as a neurotransmitter, a molecule should meet several criteria: it needs to be stored within a synaptic vesicle in a neuron and be released upon neuronal stimulation; it needs to act upon a postsynaptic receptor; and afterwards, it needs to be removed or retrieved from the synaptic cleft (Kandel et al., 2021; Purves, 2018; Radian et al., 1986; Pacholczyk et al., 1991). Curiously, several molecules widely accepted as neurotransmitters only meet some, rather than all, of these criteria (Curtis and Watkins, 1960; Felix and Künzle, 1974). Accurately detecting candidate molecules within synaptic vesicles could represent a significant step towards identifying neurotransmitters with a higher certainty.

Now, in eLife, Yi Rao and colleagues at Peking University and other research centers in Beijing – including Xiling Bian, Jiemin Zhu and Xiaobo Jia as joint first authors – report data that potentially uncovers a new neurotransmitter within the mammalian brain (Bian et al., 2023). The researchers used a combination of mass spectrometry, genetics, biochemistry, immunostaining, electrophysiology, and electron microscopy to support this conclusion.

Starting with purified synaptic vesicles (SV) from mouse brains, Bian et al. detected several well-known neurotransmitters in their samples, as well as creatine. The levels of SV creatine were higher than those of other known neurotransmitters, such as acetylcholine and serotonin, but lower than glutamate and gamma-aminobutyric acid (GABA). It has been known for decades that creatine is involved in recycling ATP in both muscle and brain tissue (Wyss and Kaddurah-Daouk, 2000; Brosnan and Brosnan, 2007; Wallimann et al., 2011). And more recently, researchers have suggested that it might also have additional roles in brain function (Ohtsuki et al., 2002; Braissant et al., 2011).

The next step was to dissect the molecular mechanism of creatine function in neurons. Bian et al. demonstrated that creatine was released from stimulated coronal brain slices. Interestingly, creatine release was reduced in slices from mice lacking either the gene that codes for an enzyme called AGAT (which is necessary for creatine production), or the gene that codes for the SLC6A8 creatine transporter. Importantly, the Bian et al. also observed that creatine has an inhibitory effect on a subset of neurons. They also found that SLC6A8 can move creatine into synaptosomes (isolated synaptic structures that contain a machine that helps release neurotransmitters and large numbers of synaptic vesicles). Collectively, these results are consistent with creatine acting like a neurotransmitter and with AGAT and SLC6A8 supporting that function (Figure 1).

Schematic illustration of the synthesis, transport and release of creatine in neurons.

A subtype of glial cell, known as an astrocyte (orange), likely synthesizes creatine molecules (red dots) through a process involving the amino acids glycine (Gly) and arginine (Arg), the enzymes AGAT and GAMT, and other compounds (GAA and SAM; Roschel et al., 2021). It is likely that the creatine molecules are then transported into a synaptic vesicle located in a presynaptic neuron that expresses a creatine transporter (CreaT) called SLC6A8. SNARE proteins (string-like structures) then mediate the release of the vesicles containing the creatine molecules into the synaptic cleft in a calcium-dependent manner, and the creatine molecules go on to bind to an as-yet unidentified creatine receptor (CreaR) on the postsynaptic neuron. It is possible that creatine molecules are also released directly by the astrocytes into the synaptic cleft between the neurons in a calcium-independent manner. AGAT: L-arginine: glycine amidinotransferase; GAA: guanidinoacetate; GAMT: guanidinoacetate methyltransferase; SAM: S-adenosylmethionine.

Image created with BioRender.com.

The work by Bian et al. goes beyond previous studies, which posited that creatine could have neurotransmitter-like properties (Almeida et al., 2006; Peral et al., 2010). Nevertheless, questions remain for future work. Most notably, Bian et al. did not identify a specific postsynaptic receptor for creatine. The researchers speculate that there might be a metabotropic receptor (or receptors) for creatine (Figure 1). Another mystery is that most of the creatine release after high potassium stimulation occurs when there is no extracellular calcium present. This is not consistent with a neurotransmitter role for that portion of the release. Bian et al. speculate that astrocytes might be responsible because astrocytes contain high levels of an enzyme called GAMT, which is involved in the production of creatine. If this idea were correct, then astrocytic creatine could potentially serve a neuromodulatory role. One final puzzle is that AGAT and SLC6A8 are found in different cells in the brain. So if creatine were a neurotransmitter, it suggests a complex model of creatine being synthesized in one cell type and subsequently then transported to another cell type for release (Figure 1).

In summary, Bian et al. report that creatine is a possible neurotransmitter in the central nervous system and that it meets several textbook criteria for a neurotransmitter (Kandel et al., 2021; Purves, 2018). This is a potentially groundbreaking finding that could have implications for understanding brain function and neurotransmission. It may also open new areas of understanding Creatine Transporter Deficiency, which manifests as a collection of intellectual disabilities, language delays and other neurological disorders that are associated with defective SLC6A8 (Salomons et al., 2003).

References

    1. Benfenati F
    2. Agnati LF
    (1991)
    Communication and computation in the central nervous system
    Functional Neurology 6:202–209.
    1. Carlsson A
    2. Falck B
    3. Hillarp NA
    (1962)
    Cellular localization of brain monoamines
    Acta Physiologica Scandinavica 56:1–28.
  1. Book
    1. Kandel ER
    2. Koester JD
    3. Mack SH
    4. Siegelbaum SA
    (2021)
    Principles of Neural Sciences (6th Edition)
    McGraw-Hill.
    1. Lovinger DM
    (2008)
    Communication networks in the brain: neurons, receptors, neurotransmitters, and alcohol
    Alcohol Research & Health 31:196–214.
  2. Book
    1. Purves D
    (2018)
    Neuroscience
    New York: Oxford University Press.
    1. Radian R
    2. Bendahan A
    3. Kanner BI
    (1986)
    Purification and identification of the functional sodium- and chloride-coupled gamma-aminobutyric acid transport glycoprotein from rat brain
    The Journal of Biological Chemistry 261:15437–15441.

Article and author information

Author details

  1. Bhagaban Mallik

    Bhagaban Mallik is in the Department of Anatomy and Cell Biology, University of Iowa, Iowa City, United States

    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7637-3338
  2. C Andrew Frank

    C Andrew Frank is in the Department of Anatomy and Cell Biology, University of Iowa, Iowa City, United States

    For correspondence
    andy-frank@uiowa.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9599-421X

Publication history

  1. Version of Record published: October 16, 2023 (version 1)

Copyright

© 2023, Mallik and Frank

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,669
    views
  • 288
    downloads
  • 0
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Bhagaban Mallik
  2. C Andrew Frank
(2023)
Central Nervous System: Is creatine a CNS neurotransmitter?
eLife 12:e91824.
https://doi.org/10.7554/eLife.91824

Further reading

    1. Neuroscience
    Ya-Hui Lin, Li-Wen Wang ... Li-An Chu
    Research Article

    Tissue-clearing and labeling techniques have revolutionized brain-wide imaging and analysis, yet their application to clinical formalin-fixed paraffin-embedded (FFPE) blocks remains challenging. We introduce HIF-Clear, a novel method for efficiently clearing and labeling centimeter-thick FFPE specimens using elevated temperature and concentrated detergents. HIF-Clear with multi-round immunolabeling reveals neuron circuitry regulating multiple neurotransmitter systems in a whole FFPE mouse brain and is able to be used as the evaluation of disease treatment efficiency. HIF-Clear also supports expansion microscopy and can be performed on a non-sectioned 15-year-old FFPE specimen, as well as a 3-month formalin-fixed mouse brain. Thus, HIF-Clear represents a feasible approach for researching archived FFPE specimens for future neuroscientific and 3D neuropathological analyses.

    1. Neuroscience
    Amanda Chu, Nicholas T Gordon ... Michael A McDannald
    Research Article

    Pavlovian fear conditioning has been extensively used to study the behavioral and neural basis of defensive systems. In a typical procedure, a cue is paired with foot shock, and subsequent cue presentation elicits freezing, a behavior theoretically linked to predator detection. Studies have since shown a fear conditioned cue can elicit locomotion, a behavior that - in addition to jumping, and rearing - is theoretically linked to imminent or occurring predation. A criticism of studies observing fear conditioned cue-elicited locomotion is that responding is non-associative. We gave rats Pavlovian fear discrimination over a baseline of reward seeking. TTL-triggered cameras captured 5 behavior frames/s around cue presentation. Experiment 1 examined the emergence of danger-specific behaviors over fear acquisition. Experiment 2 examined the expression of danger-specific behaviors in fear extinction. In total, we scored 112,000 frames for nine discrete behavior categories. Temporal ethograms show that during acquisition, a fear conditioned cue suppresses reward seeking and elicits freezing, but also elicits locomotion, jumping, and rearing - all of which are maximal when foot shock is imminent. During extinction, a fear conditioned cue most prominently suppresses reward seeking, and elicits locomotion that is timed to shock delivery. The independent expression of these behaviors in both experiments reveal a fear conditioned cue to orchestrate a temporally organized suite of behaviors.